HomeCompareADMP vs EPRT

ADMP vs EPRT: Dividend Comparison 2026

ADMP yields 258.06% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADMP wins by $563.83M in total portfolio value
10 years
ADMP
ADMP
● Live price
258.06%
Share price
$0.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$563.90M
Annual income
$319,983,732.54
Full ADMP calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — ADMP vs EPRT

📍 ADMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADMPEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADMP + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADMP pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADMP
Annual income on $10K today (after 15% tax)
$21,935.48/yr
After 10yr DRIP, annual income (after tax)
$271,986,172.66/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, ADMP beats the other by $271,974,977.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADMP + EPRT for your $10,000?

ADMP: 50%EPRT: 50%
100% EPRT50/50100% ADMP
Portfolio after 10yr
$281.98M
Annual income
$159,998,451.70/yr
Blended yield
56.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

ADMP
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-59.7
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADMP buys
0
EPRT buys
0
No recent congressional trades found for ADMP or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADMPEPRT
Forward yield258.06%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$563.90M$64.3K
Annual income after 10y$319,983,732.54$13,170.85
Total dividends collected$538.16M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ADMP vs EPRT ($10,000, DRIP)

YearADMP PortfolioADMP Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$36,506$25,806.45$11,212$512.01+$25.3KADMP
2$127,109$88,046.91$12,689$692.09+$114.4KADMP
3$422,514$286,507.78$14,521$944.30+$408.0KADMP
4$1,342,148$890,057.94$16,841$1,302.88+$1.33MADMP
5$4,078,469$2,642,370.06$19,841$1,821.64+$4.06MADMP
6$11,868,198$7,504,236.72$23,818$2,587.47+$11.84MADMP
7$33,107,440$20,408,468.42$29,230$3,744.65+$33.08MADMP
8$88,631,800$53,206,838.59$36,816$5,540.38+$88.59MADMP
9$227,957,353$133,121,327.57$47,806$8,413.17+$227.91MADMP
10$563,898,101$319,983,732.54$64,324$13,170.85+$563.83MADMP

ADMP vs EPRT: Complete Analysis 2026

ADMPStock

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Full ADMP Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this ADMP vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADMP vs SCHDADMP vs JEPIADMP vs OADMP vs KOADMP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.